These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Successful conversion of equine atrial fibrillation using oral flecainide. Risberg AI; McGuirk SM J Vet Intern Med; 2006; 20(1):207-9. PubMed ID: 16496944 [No Abstract] [Full Text] [Related]
8. [Propafenone, flecainide, procainamide in the treatment of a fresh attack of atrial fibrillation]. Kosmala W; Kucharski W; HaczyĆski J; Kobusiak-Prokopowicz M Wiad Lek; 1994; 47(21-24):801-7. PubMed ID: 8999690 [TBL] [Abstract][Full Text] [Related]
9. Best evidence topic report. Amiodarone or flecainide for cardioversion in acute onset atrial fibrillation. Argall J; Crawford I Emerg Med J; 2004 Mar; 21(2):199. PubMed ID: 14988348 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia. Hellestrand KJ Am J Cardiol; 1996 Jan; 77(3):83A-88A. PubMed ID: 8607396 [TBL] [Abstract][Full Text] [Related]
11. Low-dose flecainide infusion followed by oral pilsicainide is highly effective and safe for paroxysmal atrial fibrillation. Nagai S; Takeishi Y; Kubota I Cardiovasc Drugs Ther; 2003 Jan; 17(1):95-7. PubMed ID: 12916520 [TBL] [Abstract][Full Text] [Related]
12. Beta1-adrenoceptor polymorphism predicts flecainide action in patients with atrial fibrillation. Nia AM; Caglayan E; Gassanov N; Zimmermann T; Aslan O; Hellmich M; Duru F; Erdmann E; Rosenkranz S; Er F PLoS One; 2010 Jul; 5(7):e11421. PubMed ID: 20625396 [TBL] [Abstract][Full Text] [Related]
13. [Effectiveness and side effects of the treatment with propafenone and flecainide for recent-onset atrial fibrillation]. Romano S; Fattore L; Toscano G; Corsini F; Coppo A; Catanzaro M; Romano A; Martone A; Caccavale F; Iodice E; Di Maggio O; Corsini G Ital Heart J Suppl; 2001 Jan; 2(1):41-5. PubMed ID: 11216083 [TBL] [Abstract][Full Text] [Related]
14. Treatment of chronic atrial fibrillation in the horse with flecainide: personal observation. Birettoni F; Porciello F; Rishniw M; della Rocca G; Di Salvo A; Sgorbini M Vet Res Commun; 2007 Aug; 31 Suppl 1():273-5. PubMed ID: 17682893 [No Abstract] [Full Text] [Related]
15. Flecainide or propafenone vs. vernakalant for conversion of recent-onset atrial fibrillation. Conde D; Costabel JP; Aragon M; Caro M; Ferro A; Klein A; Trivi M; Giniger A Can J Cardiol; 2013 Oct; 29(10):1330.e13. PubMed ID: 23465347 [No Abstract] [Full Text] [Related]
16. A symposium: Supraventricular Arrhythmias: Update 1995. Boston, Massachusetts, May 6, 1995. Am J Cardiol; 1996 Jan; 77(3):1A-95A. PubMed ID: 8607386 [No Abstract] [Full Text] [Related]
17. Confused and Too Long: Neurotoxicity and Cardiac Toxicity of Flecainide. Tsai TF; Garcia RT; Bui JQ; Thinda A; Amsterdam EA Crit Pathw Cardiol; 2017 Mar; 16(1):42-45. PubMed ID: 28195943 [No Abstract] [Full Text] [Related]
18. Flecainide and propafenone induced ST-segment elevation in patients with atrial fibrillation: clue to specificity of Brugada-type electrocardiographic changes. Beldner S; Lin D; Marchlinski FE Am J Cardiol; 2004 Nov; 94(9):1184-5. PubMed ID: 15518618 [TBL] [Abstract][Full Text] [Related]
19. Antiarrhythmic drugs in the management of atrial fibrillation. Cowan JC Br Heart J; 1993 Oct; 70(4):304-6. PubMed ID: 8217437 [No Abstract] [Full Text] [Related]
20. Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation. Aliot E; Capucci A; Crijns HJ; Goette A; Tamargo J Europace; 2011 Feb; 13(2):161-73. PubMed ID: 21138930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]